Jump to content

Ethyl dirazepate

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Keenan Pepper (talk | contribs) at 22:11, 12 July 2010 (Category:Ethyl esters). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Ethyl dirazepate
Identifiers
  • ethyl 7-chloro-5-(2-chlorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepine-3-carboxylate
CAS Number
PubChem CID
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC18H14Cl2N2O3
Molar mass377.221 g·mol−1
3D model (JSmol)
  • CCOC(=O)C1C(=O)NC2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3Cl

Ethyl dirazepate is a drug which is a benzodiazepine derivative which was developed by Sanofi Winthrop. It has anxiolytic and hypnotic and possibly other characteristic benzodiazepine properties.[1][2][3]

Stub icon

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

See also

References

  1. ^ "ethyl dirazepate". psychotropics.dk. 2003. Retrieved 7 December 2009.
  2. ^ "Drugs of the Future". Thomson Reuters. 6 (11). November 1981.
  3. ^ "LIST OF INTERNATIONAL NON-PROPRIETARY NAMES (INNS), PROVIDED FOR PHARMACEUTICAL SUBSTANCES BY THE WORLD HEALTH ORGANIZATION, WHICH ARE FREE OF DUTY" (PDF). Official Journal of the European Communities. eur-lex.europa.eu. 23 October 2001. Retrieved 7 December 2009.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Ethyl_dirazepate&oldid=373155619"